 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Total Thyroidectomy With Harmonic Scalpel®
|
|
|
|
Phase IV
|
|
|
|
CP005
NCT00385983
|
|
| |
Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer
|
|
|
|
Phase IV
|
|
|
|
Dathyrca 1
EudrCT 2007-002713-39, HB-2007-043, Data register 2007-41-120, NCT00604318
|
|
| |
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
|
|
|
|
Phase III, Phase II
|
|
|
|
06-2247
NCT00442533
|
|
| |
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
OXC4T4-302
NCT00507429
|
|
| |
Iodine I 131 With or Without Thyroid-Stimulating Hormone in Treating Patients Who Have Undergone Surgery for Thyroid Cancer
|
|
|
|
Phase III
|
|
|
|
CRUK-HILO-BRD/05/83
ISRCTN56078540, EU-20665, CTA-20363/0217/001/0001, EUDRACT-2005-003687-37, NCT00415233
|
|
| |
Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients
|
|
|
|
Phase III
|
|
|
|
Estimabl
CSET 1216, NCT00435851
|
|
| |
Phase 3 Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer
|
|
|
|
Phase III
|
|
|
|
XL184-301
NCT00704730
|
|
| |
The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer
|
|
|
|
Phase III
|
|
|
|
UAlexandria
NCT00794053
|
|
| |
Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
|
|
|
|
Phase III
|
|
|
|
SMC IRB 2008-09-048
NCT00795782
|
|
| |
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
CTCT 06-11
NCT00493883
|
|
